FTC challenges 'junk' patents held by 10 drugmakers, incl Novo Nordisk's Ozempic

Good.

They patented inhalers for a second time. It's the exact same drug. The only thing that changed was the propellant. It went from R-12 to R-134a. Everyone who had to switch out R-12 from refrigeration to drug manufacturing switched to R-134a. There was absolutely _nothing_ novel about it.

It was _criminal_ to allow them the second patent for just the propellant change. It took generic $5 inhalers off the market and replaced them with $95 inhalers. It was was one of the most corrupt swindles I've ever personally seen.

The exact same refrigerants that were used in US automotive air-conditioning, although now they moved on or are moving from R-134a to HFO-1234yf.

I still have a dozen vintage cans of R-12 but no vehicle that uses them.